carmustine medac (previously carmustine obvius)
medac gesellschaft für klinische spezialpräparate mbh - carmustine - hodgkin disease; lymphoma, non-hodgkin - antinavikiniai vaistai - carmustine is indicated n adults in the following malignant neoplasms as a single agent or in combination with other antineoplastic agents and/or other therapeutic measures (radiotherapy, surgery): , brain tumours (glioblastoma, brain-stem gliomas, medulloblastoma, astrocytoma and ependymoma), brain metastases, secondary therapy in non-hodgkin’s lymphoma and hodgkin’s disease, as conditioning treatment prior to autologous haematopoietic progenitor cell transplantation (hpct) in malignant haematological diseases (hodgkin’s disease / non-hodgkin’s lymphoma).
gefitinib norameda
norameda, uab - gefitinibas - plėvele dengtos tabletės - 250 mg - gefitinib
rudotel
teva pharma b.v. - medazepamas - tabletės - 10 mg - medazepam
barii sulfas medana
medana pharma sa - bario sulfatas - geriamoji ar tiesiosios žarnos suspensija - 1 g/ml - barium sulfate with suspending agents
asparaginase medac
medac gesellschaft für klinische spezialpräparate mbh - asparaginazė - milteliai injekciniam tirpalui - 10000 v; 5000 v - asparaginase
capecitabine norameda
norameda, uab - kapecitabinas - plėvele dengtos tabletės - 150 mg; 500 mg - capecitabine
gemcitabine medac
medac gesellschaft für klinische spezialpräparate mbh - gemcitabinas - milteliai infuziniam tirpalui - 38 mg/ml - gemcitabine
mitomycin medac
medac gesellschaft für klinische spezialpräparate mbh - mitomicinas - milteliai šlapimo pūslės tirpalui ar injekciniam tirpalui - 1 mg/ml - mitomycin
pemetrexed norameda
norameda, uab - pemetreksedas - milteliai infuzinio tirpalo koncentratui - 100 mg; 500 mg - pemetrexed
zoledronic acid norameda
norameda, uab - zoledrono rūgštis - koncentratas infuziniam tirpalui - 4 mg/5 ml - zoledronic acid